| aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ... Journal of Hepatology 73 (6), 1368-1378, 2020 | 205 | 2020 |
| Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes HA Innes, SA McDonald, JF Dillon, S Allen, PC Hayes, D Goldberg, ... Hepatology 62 (2), 355-364, 2015 | 142 | 2015 |
| The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen H Innes, ST Barclay, PC Hayes, A Fraser, JF Dillon, A Stanley, A Bathgate, ... Journal of hepatology 68 (4), 646-654, 2018 | 117 | 2018 |
| Factors associated with spontaneous clearance of chronic hepatitis C virus infection N Bulteel, PP Sarathy, E Forrest, AJ Stanley, H Innes, PR Mills, H Valerio, ... Journal of hepatology 65 (2), 266-272, 2016 | 108 | 2016 |
| The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: an international study M Alavi, NZ Janjua, M Chong, J Grebely, EJ Aspinall, H Innes, HM Valerio, ... Journal of hepatology 68 (3), 393-401, 2018 | 84 | 2018 |
| Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost‐effectiveness HA Innes, SJ Hutchinson, S Barclay, E Cadzow, JF Dillon, A Fraser, ... Hepatology 57 (2), 451-460, 2013 | 84 | 2013 |
| Excess liver‐related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care HA Innes, SJ Hutchinson, S Allen, D Bhattacharyya, P Bramley, ... Hepatology 54 (5), 1547-1558, 2011 | 80 | 2011 |
| Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most? H Innes, D Goldberg, J Dillon, SJ Hutchinson Gut 64 (11), 1800-1809, 2015 | 74 | 2015 |
| Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population H Innes, S McDonald, P Hayes, JF Dillon, S Allen, D Goldberg, PR Mills, ... Journal of Hepatology 66 (1), 19-27, 2017 | 71 | 2017 |
| Genome-wide association study for alcohol-related cirrhosis identifies risk loci in MARC1 and HNRNPUL1 H Innes, S Buch, S Hutchinson, IN Guha, JR Morling, E Barnes, W Irving, ... Gastroenterology 159 (4), 1276-1289. e7, 2020 | 56 | 2020 |
| Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs A Weir, A McLeod, H Innes, H Valerio, EJ Aspinall, DJ Goldberg, ... Drug and alcohol dependence 165, 53-60, 2016 | 54 | 2016 |
| Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe NE Palmateer, SJ Hutchinson, H Innes, C Schnier, O Wu, DJ Goldberg, ... International Journal of Drug Policy 24 (2), 85-100, 2013 | 49 | 2013 |
| Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland G McAllister, H Innes, A Mcleod, JF Dillon, PC Hayes, R Fox, ST Barclay, ... Journal of Clinical Virology 61 (3), 359-364, 2014 | 47 | 2014 |
| Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland HA Innes, SJ Hutchinson, S Allen, D Bhattacharyya, P Bramley, B Carman, ... European journal of gastroenterology & hepatology 24 (6), 646-655, 2012 | 44 | 2012 |
| Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment EJ Aspinall, SJ Hutchinson, NZ Janjua, J Grebely, A Yu, M Alavi, J Amin, ... Journal of hepatology 62 (2), 269-277, 2015 | 42 | 2015 |
| Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of S cotland's … SA McDonald, SJ Hutchinson, HA Innes, S Allen, P Bramley, ... Journal of viral hepatitis 21 (5), 366-376, 2014 | 42 | 2014 |
| Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe)–a natural experiment (protocol) M Hickman, JF Dillon, L Elliott, D De Angelis, P Vickerman, G Foster, ... BMJ open 9 (9), e029538, 2019 | 40 | 2019 |
| Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience SJ Hutchinson, JF Dillon, R Fox, SA McDonald, HA Innes, A Weir, ... International Journal of Drug Policy 26 (11), 1041-1049, 2015 | 40 | 2015 |
| Geospatial mapping and data linkage uncovers variability in outcomes of foot disease according to multiple deprivation: a population cohort study of people with diabetes JE Hurst, R Barn, L Gibson, H Innes, SA Bus, B Kennon, D Wylie, ... Diabetologia 63, 659-667, 2020 | 35 | 2020 |
| Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis SA McDonald, KG Pollock, ST Barclay, DJ Goldberg, A Bathgate, ... Journal of viral hepatitis 27 (3), 270-280, 2020 | 35 | 2020 |
